Wandercraft, a developer of robotic mobility systems, has secured $75m in Series D funding to support its ongoing growth in the fields of clinical, consumer, and industrial robotics.
The funding round saw participation from Renault Group, the PSIM fund managed by Bpifrance under the France 2030 initiative, Teampact Ventures, and Quadrant Management.
The funds are earmarked for advancing Eve, the self-balancing personal exoskeleton, targeting a market release by 2026.
Additionally, the company aims to enhance the clinical reach of its Atalante X rehabilitation system and further develop its humanoid robot, Calvin-40.
Wandercraft CEO and co-founder Matthieu Masselin said: “The momentum we’ve achieved over the past few years is extraordinary.
“We’ve expanded globally, launched pivotal clinical trials, readied the commercialisation of Eve, our personal exoskeleton, and entered a landmark partnership with Renault Group.
“This funding allows us to continue our mission of transforming how people live, move, and work across rehabilitation, home environments, and soon on factory floors.”
Renault Group’s involvement marks a strategic partnership, with the car manufacturer acquiring a minority stake in Wandercraft. This collaboration leverages Renault’s industrial expertise to scale the production of exoskeletons and industrial robots, facilitating cost-effective manufacturing of Eve and the Calvin humanoid series.
Renault is also the first commercial partner and customer for Calvin-40, a robot designed for demanding industrial tasks, developed in just 40 days.
Calvin-40 stands out as the first industrial-grade humanoid robot from a European company. Its swift development was achieved through Wandercraft’s advanced robotics platform, integrated with NVIDIA’s Isaac technologies, including the GR00T N1 foundation model and Jetson edge AI platform.
The Series D funding is set to accelerate the commercial deployment of Eve in various environments, support further growth of Atalante X, and expand the industrial rollout of Calvin-40 and its related robotic family.
The latest announcement follows significant growth since Wandercraft’s Series C funding round of $45m, led by Quadrant Management, which facilitated US market expansion and a substantial revenue increase.
Additional participants in the Series D round include LBO France, Mutuelles Impact managed by XAnge, Cemag Invest, Martagon Capital, and AG2R LA MONDIALE.
